Glenn S. Slavin
GE Healthcare
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Glenn S. Slavin.
Circulation | 2008
Srinivas R. Dukkipati; Richard Philip Mallozzi; Ehud J Schmidt; Godtfred Holmvang; Andre d'Avila; Renee Guhde; Robert David Darrow; Glenn S. Slavin; Maggie Fung; Zachary J. Malchano; Greg Kampa; Jeremy D. Dando; Christina D. McPherson; Thomas Kwok-Fah Foo; Jeremy N. Ruskin; Charles Lucian Dumoulin; Vivek Y. Reddy
Background— X-ray fluoroscopy constitutes the fundamental imaging modality for catheter visualization during interventional electrophysiology procedures. The minimal tissue discriminative capability of fluoroscopy is mitigated in part by the use of electroanatomic mapping systems and enhanced by the integration of preacquired 3-dimensional imaging of the heart with computed tomographic or magnetic resonance (MR) imaging. A more ideal paradigm might be to use intraprocedural MR imaging to directly image and guide catheter mapping procedures. Methods and Results— An MR imaging–based electroanatomic mapping system was designed to assess the feasibility of navigating catheters to the left ventricle in vivo using MR tracking of microcoils incorporated into the catheters, measuring intracardiac ventricular electrograms, and integrating this information with 3-dimensional MR angiography and myocardial delayed enhancement images to allow ventricular substrate mapping. In all animals (4 normal, and 10 chronically infarcted swine), after transseptal puncture under fluoroscopic guidance, catheters were successfully navigated to the left ventricle with MR tracking (13 to 15 frames per second) by both transseptal and retrograde aortic approaches. Electrogram artifacts related to the MR imaging gradient pulses were successfully removed with analog and digital signal processing. In all animals, it was possible to map the entire left ventricle and to project electrogram voltage amplitude maps to identify the scarred myocardium. Conclusions— It is possible to use MR tracking to navigate catheters to the left ventricle, to measure electrogram activity, and to render accurate 3-dimensional voltage maps in a porcine model of chronic myocardial infarction, completely in the MR imaging environment. Myocardial delayed enhancement guidance provided dense sampling of the proximity of the infarct and accurate localization of complex infarcts.
Circulation-arrhythmia and Electrophysiology | 2009
Ehud J. Schmidt; Richard Philip Mallozzi; Aravinda Thiagalingam; Godtfred Holmvang; Andre d'Avila; Renee Guhde; Robert David Darrow; Glenn S. Slavin; Maggie Fung; Jeremy D. Dando; Lori Foley; Charles Lucian Dumoulin; Vivek Y. Reddy
Background—The MRI-compatible electrophysiology system previously used for MR-guided left ventricular electroanatomic mapping was enhanced with improved MR tracking, an MR-compatible radiofrequency ablation system and higher-resolution imaging sequences to enable mapping, ablation, and ablation monitoring in smaller cardiac structures. MR-tracked navigation was performed to the left atrium (LA) and atrioventricular (AV) node, followed by LA electroanatomic mapping and radiofrequency ablation of the pulmonary veins (PVs) and AV node. Methods and Results—One ventricular ablation, 7 PV ablations, 3 LA mappings, and 3 AV node ablations were conducted. Three MRI-compatible devices (ablation/mapping catheter, torqueable sheath, stimulation/pacing catheter) were used, each with 4 to 5 tracking microcoils. Transseptal puncture was performed under x-ray, with all other procedural steps performed in the MRI. Preacquired MRI roadmaps served for real-time catheter navigation. Simultaneous tracking of 3 devices was performed at 13 frames per second. LA mapping and PV radiofrequency ablation were performed using tracked ablation catheters and sheaths. Ablation points were registered and verified after ablation using 3D myocardial delayed enhancement and postmortem gross tissue examination. Complete LA electroanatomic mapping was achieved in 3 of 3 pigs, Right inferior PV circumferential ablation was achieved in 3 of 7 pigs, with incomplete isolation caused by limited catheter deflection. During AV node ablation, ventricular pacing was performed, 3 devices were simultaneously tracked, and intracardiac ECGs were displayed. 3D myocardial delayed enhancement visualized node injury 2 minutes after ablation. AV node block succeeded in 2 of 3 pigs, with 1 temporary block. Conclusions—LA mapping, PV radiofrequency ablation, and AV node ablation were demonstrated under MRI guidance. Intraprocedural 3D myocardial delayed enhancement assessed lesion positional accuracy and dimensions.
European Journal of Echocardiography | 2014
Andris H. Ellims; Leah M. Iles; L. Ling; Belinda Chong; Ivan Macciocca; Glenn S. Slavin; James L. Hare; David M. Kaye; Silvana Marasco; Catriona McLean; Paul A. James; Desirée du Sart; Andrew J. Taylor
AIMS In hypertrophic cardiomyopathy (HCM), attempts to associate genotype with phenotype have largely been unsuccessful. More recently, cardiac magnetic resonance (CMR) imaging has enhanced myocardial fibrosis characterization, while next-generation sequencing (NGS) can identify pathogenic HCM mutations. We used CMR and NGS to explore the link between genotype and fibrotic phenotype in HCM. METHODS AND RESULTS One hundred and thirty-nine patients with HCM and 25 healthy controls underwent CMR to quantify regional myocardial fibrosis with late gadolinium enhancement (LGE) and diffuse myocardial fibrosis with post-contrast T1 mapping. Collagen content of myectomy specimens from nine HCM patients was determined. Fifty-six HCM patients underwent NGS for 65 cardiomyopathy genes, including 36 HCM-associated genes. Post-contrast myocardial T1 time correlated histologically with myocardial collagen content (r = -0.70, P = 0.03). Compared with controls, HCM patients had more LGE (4.6 ± 6.1 vs. 0%, P < 0.001) and lower post-contrast T1 time (483 ± 83 vs. 545 ± 49 ms, P < 0.001). LGE negatively correlated with left-ventricular (LV) ejection fraction and outflow tract obstruction, whereas lower post-contrast T1 time, suggestive of more diffuse myocardial fibrosis, was associated with LV diastolic impairment and dyspnoea. Patients with identifiable HCM mutations had more LGE (7.9 ± 8.6 vs. 3.1 ± 4.3%, P = 0.03), but higher post-contrast T1 time (498 ± 81 vs. 451 ± 70 ms, P = 0.03) than patients without. CONCLUSION In HCM, contrast-enhanced CMR with T1 mapping can non-invasively evaluate regional and diffuse patterns of myocardial fibrosis. These patterns of fibrosis occur independently of each other and exhibit distinct clinical associations. HCM patients with recognized genetic mutations have significantly more regional, but less diffuse myocardial fibrosis than those without.
Magnetic Resonance in Medicine | 2012
Ting Song; Jeffrey A. Stainsby; Vincent B. Ho; Maureen N. Hood; Glenn S. Slavin
A modified Look–Locker acquisition using saturation recovery (MLLSR) for breath‐held myocardial T1 mapping is presented. Despite its reduced dynamic range, saturation recovery enables substantially higher imaging efficiency than conventional inversion recovery T1 mapping because it does not require time for magnetization to relax to equilibrium. Therefore, MLLSR enables segmented readouts, shorter data acquisition windows, and shorter breath holds compared with inversion recovery. T1 measurements in phantoms using MLLSR showed a high correlation with conventional single‐point inversion recovery spin echo. In vivo T1 measurements from normal and infarcted myocardium in 41 volunteers and patients were consistent with previously reported values. Twenty subjects were also scanned with MLLSR using an accelerated sampling scheme that required half the scan time (eight vs. 16 heartbeats) but yielded equivalent results. The flexibility afforded by the improved imaging efficiency of MLLSR allows the acquisition to be tailored to particular clinical needs and to individual patients breath‐holding abilities. Magn Reson Med, 2012.
Journal of Cardiovascular Magnetic Resonance | 2013
Glenn S. Slavin; Jeff A Stainsby
Background SMART1Map is a new single-point technique for cardiac T1 mapping [1]. Unlike Look-Locker approaches, such as MOLLI, which yield an “apparent” T1 (T1*), SMART1Map directly measures true T1. Because T1* is a function of imaging parameters, it is always shorter than T1, and correction methods are required to obtain the true T1. This work compared the accuracy of SMART1Map with MOLLI in phantom experiments under several imaging conditions.
Journal of Cardiovascular Magnetic Resonance | 2013
Jeff A Stainsby; Glenn S. Slavin
Background Recently a single-point, saturation-recovery myocardial T1 mapping sequence (SMART1Map = Saturation Method using Adaptive Recovery Times for cardiac T1 Mapping) was presented [1]. Compared to common methods like MOLLI, SMART1Map measures true T1 instead of apparent T1 relaxation, is more time efficient and can track exact TI times instead of estimated ones based on the heart rate during prescription. In this work we compare SMART1Map to MOLLI in an initial cohort of volunteers.
Journal of Cardiovascular Magnetic Resonance | 2014
Glenn S. Slavin; Maggie Fung
Background Single-phase cardiac MRI acquires data only during a brief period of the cardiac cycle. To avoid motion artifacts, the operator must select a trigger delay that corresponds to a period of minimal cardiac motion, typically at end-systole or mid-diastole. This can be done by inspecting a prior cine scan for quiescent periods. However, because these cardiac phases can vary in temporal position and duration as a function of heart rate, another option should be available if the heart rate at the time of the single-phase scan differs from that during the cine scan. The goal of this work was to analytically determine the optimal trigger delays for cardiac MRI. Methods
Journal of Cardiovascular Magnetic Resonance | 2014
Jeff A Stainsby; Glenn S. Slavin
Background Currently, MOLLI [1] is the most common method for measuring myocardial T1. Because MOLLI uses an SSFP-based Look-Locker approach, only the apparent T1 (T1*) can be measured, and there are concerns about the accuracy of the T1* values due to the dependence on imaging parameters. Alternatives to LookLocker imaging are single-point methods such as SASHA[2] and SMART1Map[3]. Although single-point methods are historically well-established and measure true T1, there remain differences between SASHA and SMART1Map that may affect their performance. Although both use single-point saturation recovery to acquire data at multiple saturation delay times (TS), the distribution of delay times is very different (Figure 1). The purpose of this work was to examine the accuracy and precision of MOLLI, SASHA, and SMART1Map in a phantom study.
Journal of Cardiovascular Magnetic Resonance | 2014
Glenn S. Slavin
Background MOLLI [1] uses interleaved Look-Locker (LL) blocks for cardiac T1 mapping. Data is fit to the equation A-Bexp (-TI/T1*) to yield an “apparent” T1 (T1*), which is dependent on both the true T1 and imaging parameters. To estimate true T1, a “LL correction” T1est=(B/A-1) T1* [Eq. 1] has been proposed [1,2]. Although this correction can provide reasonable estimates of true T1, we are not aware of a rigorous justification for its use. The purpose of this work was to investigate the applicability of this correction for MOLLI.
Journal of Cardiovascular Magnetic Resonance | 2010
Jeff A Stainsby; Venkat Ramanan; Glenn S. Slavin; Graham A. Wright
Introduction T2-weighted imaging in acute myocardial infarction has been suggested for detecting regions of edema. The need to carefully account for variations in coil sensitivity patterns has been noted with these techniques. An alternate approach is to generate quantitative T2 maps. In this work we compare 3 different myocardial T2 mapping methods; multi-echo double-IR FSE (MEFSE), segmented T2-prepared SSFP (T2pSSFP) similar to [1] and T2-prepared spiral (SpiralT2) [2].